March 17 (Reuters) - Next Science Ltd NXS.AX :
* DUE TO COVID19 OUTBREAK IN U.S., SEEING DISRUPTION TO ACTIVITIES INCLUDING REDUCED HOSPITAL VISITS BY DISTRIBUTION AGENTS
* SALES GROWTH HAS BEEN IMPACTED AND IS LIKELY TO CONTINUE
* TOO EARLY TO REASONABLY ANTICIPATE SALES IN Q2
* EXPECT COMMERCIAL LAUNCH OF 2 NEW PRODUCTS IN U.S. IN H2 2020